DE69819016D1 - Arginine silicate inositol komplex und dessen verwendung - Google Patents

Arginine silicate inositol komplex und dessen verwendung

Info

Publication number
DE69819016D1
DE69819016D1 DE69819016T DE69819016T DE69819016D1 DE 69819016 D1 DE69819016 D1 DE 69819016D1 DE 69819016 T DE69819016 T DE 69819016T DE 69819016 T DE69819016 T DE 69819016T DE 69819016 D1 DE69819016 D1 DE 69819016D1
Authority
DE
Germany
Prior art keywords
pct
arginine silicate
inositol complex
silicate inositol
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69819016T
Other languages
English (en)
Other versions
DE69819016T2 (de
Inventor
Mark Mccarty
Jan Zielinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutrition 21 LLC
Original Assignee
Nutrition 21 LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 LLC filed Critical Nutrition 21 LLC
Application granted granted Critical
Publication of DE69819016D1 publication Critical patent/DE69819016D1/de
Publication of DE69819016T2 publication Critical patent/DE69819016T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/04—Esters of silicic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69819016T 1997-02-12 1998-02-11 Arginine silicate inositol komplex und dessen verwendung Expired - Fee Related DE69819016T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/799,784 US5707970A (en) 1997-02-12 1997-02-12 Arginine silicate complex and use thereof
US799784 1997-02-12
PCT/US1998/002443 WO1998034647A1 (en) 1997-02-12 1998-02-11 Arginine silicate inositol complex and use thereof

Publications (2)

Publication Number Publication Date
DE69819016D1 true DE69819016D1 (de) 2003-11-20
DE69819016T2 DE69819016T2 (de) 2004-04-29

Family

ID=25176739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819016T Expired - Fee Related DE69819016T2 (de) 1997-02-12 1998-02-11 Arginine silicate inositol komplex und dessen verwendung

Country Status (16)

Country Link
US (3) US5707970A (de)
EP (1) EP1007096B1 (de)
JP (1) JP2001512443A (de)
KR (1) KR20000070977A (de)
CN (1) CN1182873C (de)
AT (1) ATE251914T1 (de)
AU (1) AU722975B2 (de)
BR (1) BR9807675A (de)
CA (1) CA2279233A1 (de)
DE (1) DE69819016T2 (de)
DK (1) DK1007096T3 (de)
ES (1) ES2209112T3 (de)
HU (1) HUP0001998A3 (de)
IL (1) IL130925A0 (de)
PT (1) PT1007096E (de)
WO (1) WO1998034647A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707970A (en) 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
WO2002008175A2 (en) * 2000-07-24 2002-01-31 Nutrition 21, Inc. Arginine saccharate and use thereof
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement
TWI283427B (en) * 2001-07-12 2007-07-01 Semiconductor Energy Lab Display device using electron source elements and method of driving same
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US7147660B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Advanced endovascular graft
MXPA05001928A (es) * 2002-08-22 2005-08-29 Nutrition 21 Inc Complejo de inositol de silicato de arginina y su empleo.
US6803456B1 (en) * 2003-08-13 2004-10-12 Rutherford Chemicals Llc Process for the production of arginine-silicate complex
US7803178B2 (en) * 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
EP1753367A4 (de) * 2004-03-11 2011-10-12 Trivascular Inc Aus elementen zusammengesetztes endovaskuläres transplantat
US7919620B2 (en) * 2005-06-01 2011-04-05 Coral Biotech Kabushiki Kaisha Agent for suppressing blood pressure elevation
ITMI20060677A1 (it) * 2006-04-06 2007-10-07 Damor Farmaceutici Profarmaci dell'arginina ad elevata attivita'terapeutica
US20100143488A1 (en) * 2006-09-21 2010-06-10 Toshiki Oguro Promoter of hard tissue regeneration
CA2681158C (en) 2007-03-13 2018-09-18 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
GB0805279D0 (en) 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
WO2012119007A1 (en) 2011-03-01 2012-09-07 N21 Acquisition Holding, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
EP3721876A1 (de) * 2015-06-30 2020-10-14 Nutrition 21, LLC Arginin-silicat-inositol zur verbesserung der kognitiven funktion
EP3322661B1 (de) 2015-07-13 2022-03-02 Otis Elevator Company Hemmschlüssel für abschreckungsvorrichtung
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
CN109069532A (zh) 2016-02-11 2018-12-21 营养21有限责任公司 含铬组合物用于改善健康和健身
JP2019526638A (ja) 2016-09-01 2019-09-19 ジェイディーエス・セラピューティクス、エルエルシー ビオチン酸マグネシウム組成物および使用方法
JP2022515314A (ja) 2018-11-02 2022-02-18 ニュートリション・２１，エルエルシー イノシトール安定化アルギニンケイ酸塩複合体及びイノシトールを含有するビデオゲームプレーヤーの認知機能を改善するための組成物
CA3165102A1 (en) 2019-12-16 2021-06-24 Nutrition 21, Llc Methods of production of arginine-silicate complexes
WO2023086567A1 (en) * 2021-11-12 2023-05-19 Nutrition21, LLC Compositions and methods for treating or preventing myopathy in poultry

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US4297349A (en) * 1980-04-15 1981-10-27 Sandoz, Inc. Silicon-bearing carboxylic acids and amides
US4385052A (en) * 1981-07-20 1983-05-24 International Plant Research Institute, Inc. Use of trialkylsilyl-6-aminonicotinamides for the treatment of psoriasis
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
US5250569A (en) * 1991-04-22 1993-10-05 Godfrey Science & Design, Inc. Amino acid flavorings of aluminum astringent for oral use
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
US5707970A (en) * 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof

Also Published As

Publication number Publication date
US6156735A (en) 2000-12-05
JP2001512443A (ja) 2001-08-21
DK1007096T3 (da) 2003-12-01
HUP0001998A2 (hu) 2000-10-28
CN1246801A (zh) 2000-03-08
CN1182873C (zh) 2005-01-05
ES2209112T3 (es) 2004-06-16
US5707970A (en) 1998-01-13
US6344444B1 (en) 2002-02-05
ATE251914T1 (de) 2003-11-15
WO1998034647A1 (en) 1998-08-13
EP1007096B1 (de) 2003-10-15
IL130925A0 (en) 2001-01-28
DE69819016T2 (de) 2004-04-29
AU722975B2 (en) 2000-08-17
HUP0001998A3 (en) 2002-01-28
PT1007096E (pt) 2004-03-31
AU6273798A (en) 1998-08-26
EP1007096A1 (de) 2000-06-14
BR9807675A (pt) 2000-02-15
CA2279233A1 (en) 1998-08-13
KR20000070977A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
DE69819016D1 (de) Arginine silicate inositol komplex und dessen verwendung
FI972164A0 (fi) Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ATE234282T1 (de) Polymorphe verbindungen
ES2169362T3 (es) Glicoconjugados de derivados modificados de la camptotecina (union al ciclo a o b).
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
MX9606503A (es) Inhibidores de pla2 y su uso para la inhibicion de la absorcion del colesterol interno.
IL126296A0 (en) Benzopyran derivatives having leukotriene antagonistic action
MY115211A (en) Novel amino acid derivatives, their preparation and use
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
NO972426L (no) Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
BG105275A (en) Tan-1057 derivatives
DE69535267D1 (de) Verwendung zur verabreichung von östrogen
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
BR0204057A (pt) Processos para geração de terahertz
DE69526731D1 (en) Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate
DE69531627D1 (de) Humane hypertrophe chrondrozyten zelllinien
ZA962946B (en) Anellated beta-carbolines
NO963988D0 (no) Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske mercaptoacetylamidderivater
ATE198315T1 (de) Dimethyl-substituierte cyclohexandienderivate
PL347584A1 (en) Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee